MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs

MASLIHAT 对注射毒品的塔吉克男性移民的干预

基本信息

项目摘要

PROJECT SUMMARY Labor migration is a major contributor to fueling the global AIDS epidemic and also the movement of HIV across country borders and populations. Migrants who inject drugs while in a host country are at especially high risk. Tajikistan, a small country in Central Asia, exports more than a million Tajiks annually, many of whom inject drugs, to work temporarily outside of their own country. Our earlier research on Tajik labor migrants in Moscow showed them to be at alarmingly high normative and behavioral risk for HIV due to risky drug use, needle sharing, alcohol consumption, and unsafe sex with casual and paid sex partners. To help curb transmission in this vulnerable population, we developed and pilot tested the "Migrants' Approached Self- Learning Intervention in HIV/AIDS for Tajiks" (MASLIHAT) prevention model. The model recruits and trains current and former Tajik migrants who inject drugs as "peer educators" in delivering the intervention to others in their social networks while simultaneously reducing their own risk. The MASLIHAT Intervention and our research efforts build synergistically on 3 theoretical models: social-cognitive-behavioral theory, social network theory and Yang's Theory of Migration. The model itself culturally adapts the successful SHIELD model, which is a CDC- designated evidence-based best practice intervention in the U.S., for use with Tajik labor migrants in Russia who inject drugs. This study will test the efficacy of the MASLIHAT intervention against a control condition designed to be equal to the intervention condition in the number of sessions, duration, and interest level. We will deliver MASLIHAT and control group interventions over 5 sessions with groups of 5 to 9 Tajik male migrants who inject drugs for a total of 10 groups for each intervention. The peer educators will share what they learned with others in their social networks, including the 2 network members who inject drugs whom they recruited for enrollment in the study. We will assess MASLIHAT and control participants and their Tajik male social network members at baseline and at 3, 6, 9 and 12 months post-intervention. We will conduct repeated measures linear and logistic regressions using mixed effect models with random person intercepts to test: (1) if greater changes in HIV risk behaviors, prevention self-efficacy, and behavioral norms occur among MASLIHAT participants (peer educators) compared to control participants, and (2) if greater changes in HIV risk behaviors, prevention self-efficacy, and behavioral norms occur among peer educator network members compared to control group network members. By transforming their own risk behavior, and encouraging others at risk to do so as well, migrant peer educators can initiate positive changes at the individual and social network levels in both their host country and also their home country when they return. The impact of the proposed study lies in the development of a much needed scientifically tested intervention that reduces HIV transmission among migrants who inject drugs within and across country borders.
项目摘要 劳动力迁移是助长全球艾滋病流行和艾滋病毒传播的主要因素 跨越国界和人口。在东道国注射毒品的移徙者特别容易受到 高风险。塔吉克斯坦是中亚的一个小国,每年出口100多万塔吉克人,其中许多人 注射毒品,暂时在国外工作。我们对塔吉克劳动力移民的早期研究 莫斯科表明,由于危险的药物使用,他们感染艾滋病毒的标准和行为风险高得惊人, 共用针头、饮酒以及与临时性伴侣和有偿性伴侣发生不安全性行为。以帮助遏制 在这个脆弱的人群中传播,我们开发并试点测试了“移民接近自我, 塔吉克人艾滋病毒/艾滋病学习干预”(MASLIHAT)预防模式。模特招募和训练 注射毒品的当前和前塔吉克移民作为“同伴教育者”向他人提供干预措施 在他们的社交网络中,同时降低他们自己的风险。MASLIHAT干预和我们的 研究工作建立在三个理论模型上:社会认知行为理论,社会网络 论和杨移民思想。模型本身在文化上适应了成功的SHIELD模型, 是美国疾控中心指定的循证最佳实践干预措施,塔吉克斯坦移民劳工使用, 俄罗斯人注射毒品。这项研究将测试MASLIHAT干预对对照组的有效性。 在会话数量、持续时间和兴趣方面与干预条件相同的条件 水平我们将提供MASLIHAT和控制组干预超过5个会议与组5至9塔吉克 每项干预措施共对10组注射毒品的男性移徙者进行调查。同伴教育者将分享 他们在社交网络中从其他人那里学到了什么,包括两名注射毒品的网络成员, 他们招募了一些人参与这项研究。我们将评估MASLIHAT和对照组参与者及其塔吉克族 男性社交网络成员在基线和干预后3,6,9和12个月。我们会进行 重复测量线性和logistic回归,使用混合效应模型,随机人截距, 测试:(1)如果艾滋病毒危险行为、预防自我效能和行为规范发生较大变化, MASLIHAT参与者(同伴教育者)与对照参与者相比,(2)如果艾滋病毒的变化更大, 同伴教育者网络成员存在危险行为、预防自我效能和行为规范 与对照组网络成员相比。通过改变自己的风险行为,并鼓励他人 移民同伴教育者可以在个人和社会层面发起积极的变革, 网络水平在他们的东道国和他们的祖国,当他们返回。的影响 一项拟议的研究在于开发一种急需的科学测试干预措施, 在国内和跨国界注射毒品的移民中传播。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HIV and Hepatitis C Risk among Tajik Migrant Workers Who Inject Drugs in Moscow.
HIV knowledge, self-perception of HIV risk, and sexual risk behaviors among male Tajik labor migrants who inject drugs in Moscow.
  • DOI:
    10.1186/s12889-023-17543-1
  • 发表时间:
    2024-01-11
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Luc, Casey Morgan;Levy, Judith;Bahromov, Mahbat;Jonbekov, Jonbek;Mackesy-Amiti, Mary E.
  • 通讯作者:
    Mackesy-Amiti, Mary E.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY ELLEN MACKESY-AMITI其他文献

MARY ELLEN MACKESY-AMITI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY ELLEN MACKESY-AMITI', 18)}}的其他基金

Promoting remote harm reduction and secondary services in rural settings (PROMOTE) study
促进农村地区减少远程伤害和二级服务 (PROMOTE) 研究
  • 批准号:
    10590281
  • 财政年份:
    2022
  • 资助金额:
    $ 51.68万
  • 项目类别:
MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs
MASLIHAT 对注射毒品的塔吉克男性移民的干预
  • 批准号:
    10217085
  • 财政年份:
    2020
  • 资助金额:
    $ 51.68万
  • 项目类别:
MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs
MASLIHAT 对注射毒品的塔吉克男性移民的干预
  • 批准号:
    10401872
  • 财政年份:
    2020
  • 资助金额:
    $ 51.68万
  • 项目类别:
MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs
MASLIHAT 对注射毒品的塔吉克男性移民的干预
  • 批准号:
    10064256
  • 财政年份:
    2020
  • 资助金额:
    $ 51.68万
  • 项目类别:
Emotion Dysregulation and Risky Behavior Among People Who Inject Drugs
注射毒品者的情绪失调和危险行为
  • 批准号:
    9271353
  • 财政年份:
    2015
  • 资助金额:
    $ 51.68万
  • 项目类别:
Emotion Dysregulation and Risky Behavior Among People Who Inject Drugs
注射毒品者的情绪失调和危险行为
  • 批准号:
    9086333
  • 财政年份:
    2015
  • 资助金额:
    $ 51.68万
  • 项目类别:
Emotion Dysregulation and Risky Behavior Among People Who Inject Drugs
注射毒品者的情绪失调和危险行为
  • 批准号:
    8845401
  • 财政年份:
    2015
  • 资助金额:
    $ 51.68万
  • 项目类别:
Patterns of Changing Risk Behavior in the CIDUS-3 Drug Users Intervention Trial
CIDUS-3 吸毒者干预试验中危险行为变化的模式
  • 批准号:
    8309943
  • 财政年份:
    2011
  • 资助金额:
    $ 51.68万
  • 项目类别:
Patterns of Changing Risk Behavior in the CIDUS-3 Drug Users Intervention Trial
CIDUS-3 吸毒者干预试验中危险行为变化的模式
  • 批准号:
    8470609
  • 财政年份:
    2011
  • 资助金额:
    $ 51.68万
  • 项目类别:
Patterns of Changing Risk Behavior in the CIDUS-3 Drug Users Intervention Trial
CIDUS-3 吸毒者干预试验中危险行为变化的模式
  • 批准号:
    8136838
  • 财政年份:
    2011
  • 资助金额:
    $ 51.68万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 51.68万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 51.68万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 51.68万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 51.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 51.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 51.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 51.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 51.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 51.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了